VCs are under pressure to improve operational capacity as competition heats up in Asia’s start-up ecosystems. Methodologies filtering over from the US are finding both disciples and skeptics
When Qiming Venture Partners first invested Gan & Lee Pharmaceuticals in 2010, the company was generating annual revenue of around RMB3 million ($435,000). It is now said to be the largest biotech company...
Novo Tellus Capital Partners has invested S$12 million ($8.8 million) in Procurri, a Singapore-listed provider of IT services and data center equipment.
Australia’s Anacacia Capital has realized the final exit from its debut fund with the sale of its majority stake in workplace equipment provider RIS Safety to domestic investor Bricktop Group.
Bain Capital has acquired a majority interest in the data center construction and maintenance division of Shenzhen-listed NetScience Technology for RMB990 million ($147 million).
Shukun, a Chinese company that provides artificial intelligence (AI) technology used in the treatment of cardiovascular diseases, has raised RMB200 million ($29 million) in a Series B round led by China Creation Ventures.